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Abstract  Imaging  myeloma  is  often  performed  when  complications  occur  which  may  reveal
the disease.  Since  the  malignant  plasma  cell  proliferation  characteristic  of  this  disease  can
affect the  whole  of  the  bony  skeleton  to  various  degrees,  examination  of  the  bones  should
be as  complete  as  possible.  The  radiographic  images  must  be  studied  for  lytic  lesions  or  signs
of diffuse  osteopenia,  as  well  for  fracture  complications  such  as  vertebral  compression.  Slice
imaging has  the  advantage  of  being  more  sensitive  and  showing  extra-osseous  extension  well.
With a  CT  scan  and  MRI,  spinal  compression  can  be  detected  or  a  surgical  procedure  planned,
while MRI  or  a  PET  scan  can  be  used  to  assess  extension  of  the  disease  and  the  response  to
treatment.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Multiple  myeloma  is  a  malignant  haematological  disease  deﬁned  as  the  proliferation  of
malignant  plasma  cells  in  the  bone  marrow  secreting  a  monoclonal  immunoglobulin  found
in  the  serum  and/or  urine.  It  is  an  incurable  disease  of  the  elderly  (the  median  age  on  diag-
nosis  is  70)  with  a  low  incidence;  about  5000  new  cases  are  diagnosed  per  year  in  France.
Myeloma  is  very  frequently  preceded  by  an  indolent  phase,  before  clinical  signs  appear.
The  myeloma  becomes  symptomatic  and  then  requires  treatment  by  chemotherapy.  The
most  common  clinical  symptoms  (in  80%  of  patients)  are  related  to  bone  lysis,  resulting
in  refractory  pain,  fracture,  vertebral  collapse  or  spinal  cord  compression.  Other  signs  of
its  clinical  evolution  are  anaemia,  hypercalcaemia,  renal  impairment,  repeated  infections
and  hyperviscosity.  Before  any  treatment,  the  patient  must  have  a  complete  radiological
examination  of  the  bones.
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Conventional radiology
Lytic  lesions  on  conventional  X-rays  are  typically  circular
punched-out  lesions,  without  reconstruction,  clearly  visible
on  the  cranial  vault,  the  iliac  bone  or  on  the  long  bones,
essentially  the  femur  and  humerus.  Vertebral  compression
is  common,  as  it  is  an  appearance  of  diffuse  osteope-
nia.
A  complete  examination  may  be  necessary  once  symp-
tomatic  myeloma  has  been  diagnosed.  It  consists  of  frontal
and  lateral  images  of  the  skull  and  of  the  cervical,  dor-
sal  and  lumbar  spine,  frontal  views  of  the  pelvis,  images
of  the  rib  cage  and  long  bones  (humerus  and  femur
only).
On  radiological  examination,  nearly  80%  of  patients  have
obvious  bone  lesions,  principally  affecting  the  spine,  in  65%
of  cases,  the  ribs,  in  45%  of  cases,  the  skull,  in  40%  of  cases,
the  shoulder,  in  40%  of  cases,  the  pelvis,  in  30%  of  cases  and
the  long  bones  in  25%  of  cases.  It  is  unusual  to  ﬁnd  lesions
of  the  elbows  or  knees  or  distal  lesions.  This  explains  why
distal  sites  are  not  systematically  imaged.  It  must  be  remem-
bered  that  bone  lesions  are  not  seen  in  10  to  20%  of  patients
despite  a  complete  radiological  examination.  This  empha-
sizes  the  limitations  of  conventional  radiology:  certain  areas
are  not  visualised,  sensitivity  is  relatively  poor  and  10  to
20%  of  lesions  are  not  seen,  speciﬁcity  is  limited  relative
to  other  benign  causes  of  osteopenia,  and  it  is  difﬁcult  to
pick  out  a  response  to  treatment.  Moreover,  the  large  num-
ber  of  images  necessary  for  diagnosis  may  be  an  obstacle
in  patients  in  extreme  pain  who  cannot  remain  lying  on  the
examination  table  for  very  long.
CT scan
CT  can  detect  small  osteolytic  lesions  in  myeloma,  which
are  not  seen  on  standard  X-rays.  CT  imaging  is  quicker  than
conventional  radiology  and  allows  excellent  reconstruction
of  images  in  three  dimensions.  In  addition,  CT  scans  can
show  precisely  the  extent  of  extra-osseous  lesions  (extra-
medullary  plasmacytomas),  and  ﬁne  needle  biopsies  can  be
taken  using  it,  to  obtain  histological  evidence  of  the  nature
of  these  lesions.  CT  has  the  following  advantages  over  con-
ventional  radiology:  the  examination  is  rapid  relative  to
standard  X-rays;  several  lesions  can  be  rapidly  evaluated  in
one  go,  without  having  to  reposition  the  patient,  particu-
larly  if  he  or  she  is  in  pain;  a  CT  scan  is  more  sensitive  than  a
standard  X-ray;  CT  examination  reveals  more  lesions,  partic-
ularly  in  areas  poorly  visualised  by  standard  radiology  such
as  the  shoulders,  ribs,  or  sternum;  CT  is  also  more  effective
for  estimating  a  risk  of  fracture  or  instability,  and  can  pick
out  extra-medullary  lesions;  CT  also  helps  plan  radiotherapy
or  a  surgical  procedure.  One  of  the  negative  points  of  CT  is
the  dose  of  radiation  delivered  to  the  patient  which  is  1.5
to  three  times  higher  than  for  a  conventional  radiograph.
MRIThis  examination  has  become  very  important  in  evaluat-
ing  myeloma  lesions.  The  advantages  of  MRI  compared
with  conventional  X-ray  imaging  are  greater  sensitivity,
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xtremely  precise  imaging  of  the  axial  skeleton,  discrimina-
ion  between  normal  and  invaded  bone  marrow,  very  precise
iagnosis  where  spinal  cord  or  neurological  compression  is
uspected,  with  very  good  visualisation  of  extra-medullary
asses,  visualisation  of  other  conditions  associated  with  the
yeloma  such  as  cardiac  amyloidosis,  and  also  an  impor-
ant  plus  value  concerning  evaluation  of  the  therapeutic
esponse,  even  if  the  lesions  may  persist  for  a  long  time
n  a  patient  with  an  excellent  therapeutic  response.
The  prognostic  value  of  MRI  has  been  evaluated  in  sev-
ral  studies.  The  number  of  lytic  lesions  is  an  important
rognostic  factor,  as  is  the  appearance  in  an  MRI  of  diffuse
nﬁltration,  which  has  a poorer  prognosis  than  more  focal
nﬁltration.  The  largest  study  in  the  literature  was  reported
y  the  group  in  Little  Rock,  Arkansas,  and  concerned  611
atients  treated  identically.  The  MRI  appearance  and  a  num-
er  of  lesions  more  than  or  equal  to  7  were  major  prognostic
actors,  more  important  than  the  cytogenetics,  and  allowed
atients  with  a  high  risk  of  evolution  to  be  distinguished
ore  easily.
ET imaging
ET  imaging  in  myeloma  is  still  not  totally  validated.  Nev-
rtheless,  more  and  more  data  suggest  that  this  technique
ill  grow  considerably  in  importance  in  the  coming  years.
ndeed,  several  groups  have  shown  that  PET  could  be  more
ensitive  than  MRI.  An  Italian  group  has  shown  that  the
umber  of  lesions  found  at  the  time  of  diagnosis  is  an  impor-
ant  prognostic  factor.  The  therapeutic  response  can  also  be
valuated  with  PET.  The  same  Italian  group  showed  that  a
egative  PET  signal  predicted  progression-free  survival  and
etter  overall  survival  for  patients  who  had  an  excellent
esponse  to  treatment.  PET  can  also  give  much  more  pre-
ise  measurement  of  the  quality  of  the  response.  In  patients
n  complete  biochemical  remission,  PET  scans  discriminate
etween  two  populations:  those  who  remain  PET  positive
espite  negative  biochemical  results  and  have  a poorer  clini-
al  future  than  the  second  group  who  are  both  biochemically
nd  PET  negative  at  the  end  of  treatment.
A  national  STIC  (Support  for  Techniques  which  are  Inno-
ative  and  Costly)  programme  is  underway  to  evaluate  the
RI/PET  comparison  prospectively  and  systematically  in  the
ontext  of  an  intensive  treatment  programme.
onclusion
n  conclusion,  the  reference  imaging  technique  for  evaluat-
ng  a  myeloma  at  the  time  of  diagnosis  is  still  conventional
adiology.  CT  and  MRI  have  better  sensitivity  and  speci-
city,  and  are  used  above  all  in  cases  of  menacing  medullary
esions.  In  the  future,  a  PET  scan  will  perhaps  be  the
tandard  examination  for  both  diagnosis  and  prognosis.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
elating  to  this  paper.
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